Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Travenol Laboratories was the primary operating name for Baxter International from the 1950s until 1985, serving as a global leader in intravenous (IV) therapy and renal care. The company was responsible for several landmark medical innovations, including the first commercially manufactured IV solutions and the first portable artificial kidney. Travenol also pioneered the development of plastic blood collection containers and the first "closed system" for IV administration, which significantly reduced infection risks in hospitals. Following a major merger with American Hospital Supply Corporation in 1985, the company consolidated its operations under the name Baxter International. Today, its legacy continues through Baxter's extensive portfolio of hospital products, dialysis technologies, and clinical nutrition services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Travanol Laboratories.